A Comprehensive Monitoring Study on Electrocardiographic Assessments and Cardiac Events After Fingolimod First Dose—Possible Predictors of Cardiac Outcomes

Background: First dose observation for cardiac effects is required for fingolimod. Previous results in patients with relapsing remitting multiple sclerosis (RRMS) suggest that transient bradycardia and conduction abnormalities during the observation phase are rare, benign and reversible. Prior analy...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Volker Limmroth, Tjalf Ziemssen, Ingo Kleiter, Bert Wagner, Stephan Schmidt, Christoph Lassek, Monika Baier-Ebert, Guillaume Wendt, Ralf Dechend, Wilhelm Haverkamp
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2020-08-01
Serie:	Frontiers in Neurology
Soggetti:	fingolimod first dose electrocardiogram cardiac effects bradycardia atrioventricular conduction
Accesso online:	https://www.frontiersin.org/article/10.3389/fneur.2020.00818/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!